scholarly article | Q13442814 |
P50 | author | Oliver Eickelberg | Q18026479 |
Olivier Coux | Q42432056 | ||
P2093 | author name string | Dietrich Trümbach | |
Silke Meiners | |||
Claire Abeza | |||
Vanessa Welk | |||
Vera Kleene | |||
P2860 | cites work | Increased proteasome activity in human embryonic stem cells is regulated by PSMD11 | Q24298544 |
The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome | Q24302180 | ||
Proteasome activator PA28 gamma regulates p53 by enhancing its MDM2-mediated degradation | Q24319027 | ||
PA200, a nuclear proteasome activator involved in DNA repair | Q24536971 | ||
A gated channel into the proteasome core particle | Q27627907 | ||
Differential global structural changes in the core particle of yeast and mouse proteasome induced by ligand binding | Q27684495 | ||
Signal integration in the endoplasmic reticulum unfolded protein response | Q27860577 | ||
Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis | Q27933881 | ||
Rpn6p, a proteasome subunit from Saccharomyces cerevisiae, is essential for the assembly and activity of the 26 S proteasome | Q27939823 | ||
Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis | Q28143710 | ||
Global quantification of mammalian gene expression control | Q28238103 | ||
Proteasome-mediated processing of Nrf1 is essential for coordinate induction of all proteasome subunits and p97 | Q28243388 | ||
Transcription factor Nrf1 mediates the proteasome recovery pathway after proteasome inhibition in mammalian cells | Q28279454 | ||
Proteasomal Degradation Is Transcriptionally Controlled by TCF11 via an ERAD-Dependent Feedback Loop | Q28295179 | ||
Evolution of proteasome regulators in eukaryotes | Q28334391 | ||
Regulation of proteasome activity in health and disease | Q28392708 | ||
Differential expression regulation of the alpha and beta subunits of the PA28 proteasome activator in mature dendritic cells | Q28509272 | ||
Recognition and processing of ubiquitin-protein conjugates by the proteasome | Q29547616 | ||
MatInspector and beyond: promoter analysis based on transcription factor binding sites | Q29616314 | ||
United States Food and Drug Administration approval summary: bortezomib for the treatment of progressive multiple myeloma after one prior therapy | Q33371230 | ||
U.s. Food and Drug Administration approval: carfilzomib for the treatment of multiple myeloma | Q33408443 | ||
Molecular and cellular roles of PI31 (PSMF1) protein in regulation of proteasome function | Q33792867 | ||
The ubiquitin-proteasome system as a drug target in cerebrovascular disease: therapeutic potential of proteasome inhibitors | Q33892755 | ||
Comparative analysis of REG{gamma} expression in mouse and human tissues | Q34042286 | ||
Proteasomes in apoptosis: villains or guardians? | Q34158571 | ||
Molecular dissection of the 11S REG (PA28) proteasome activators | Q34214167 | ||
REGγ modulates p53 activity by regulating its cellular localization | Q34329586 | ||
High yield bacterial expression and purification of active recombinant PA28alphabeta complex. | Q54413667 | ||
Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands | Q71254579 | ||
Growth retardation in mice lacking the proteasome activator PA28gamma | Q73297649 | ||
Characterization of recombinant REGalpha, REGbeta, and REGgamma proteasome activators | Q73770368 | ||
Proteasomes and proteasome activator 200 kDa (PA200) accumulate on chromatin in response to ionizing radiation | Q80379217 | ||
Purification and characterization of proteasomes from Saccharomyces cerevisiae | Q81132246 | ||
Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling | Q34506149 | ||
The axial channel of the 20S proteasome opens upon binding of the PA200 activator | Q34555139 | ||
Proteasome activator PA200 is required for normal spermatogenesis | Q34563112 | ||
Deciphering preferential interactions within supramolecular protein complexes: the proteasome case | Q35093980 | ||
Global organization and function of mammalian cytosolic proteasome pools: Implications for PA28 and 19S regulatory complexes | Q35190938 | ||
Regulation of immunoproteasome function in the lung | Q35623348 | ||
Compromising the 19S proteasome complex protects cells from reduced flux through the proteasome | Q36002378 | ||
Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors | Q36010873 | ||
Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits | Q36150369 | ||
Aging perturbs 26S proteasome assembly in Drosophila melanogaster | Q36212686 | ||
cAMP-induced phosphorylation of 26S proteasomes on Rpn6/PSMD11 enhances their activity and the degradation of misfolded proteins. | Q36435295 | ||
Proteasome allostery as a population shift between interchanging conformers | Q36483667 | ||
Role for proteasome activator PA200 and postglutamyl proteasome activity in genomic stability. | Q36945044 | ||
The REGγ proteasome regulates hepatic lipid metabolism through inhibition of autophagy | Q37269271 | ||
The proteasome activator PA200 regulates tumor cell responsiveness to glutamine and resistance to ionizing radiation. | Q37603650 | ||
Building on bortezomib: second-generation proteasome inhibitors as anti-cancer therapy | Q37684185 | ||
Proteasome activators | Q37826501 | ||
Proteasome activator 200: the heat is on... | Q37851267 | ||
Structural biology of the proteasome | Q38081952 | ||
Regulation of the proteasome: evaluating the lung proteasome as a new therapeutic target | Q38179456 | ||
Analysis of Drosophila 26 S proteasome using RNA interference | Q38294064 | ||
A role for the proteasome regulator PA28alpha in antigen presentation | Q38357921 | ||
Mammalian proteasome subtypes: Their diversity in structure and function | Q38685306 | ||
Reversible 26S proteasome disassembly upon mitochondrial stress. | Q38992225 | ||
Label-free quantitative proteomics reveals the dynamics of proteasome complexes composition and stoichiometry in a wide range of human cell lines. | Q38997541 | ||
Acute cigarette smoke exposure impairs proteasome function in the lung | Q39282499 | ||
A novel role for PA28gamma-proteasome in nuclear speckle organization and SR protein trafficking | Q40015705 | ||
Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome | Q40115986 | ||
Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway | Q40115992 | ||
Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of Mammalian proteasomes | Q40658264 | ||
Effect of histamine on proliferation of normal human adult lung fibroblasts | Q41131152 | ||
A tetrahedral transition state at the active sites of the 20S proteasome is coupled to opening of the alpha-ring channel | Q42177637 | ||
Regulation of 26S Proteasome Activity in Pulmonary Fibrosis | Q42480163 | ||
Genetic evidence linking age-dependent attenuation of the 26S proteasome with the aging process | Q43179672 | ||
Alveolar macrophage/peripheral blood monocyte-derived factors modulate proliferation of primary lines of human lung fibroblasts | Q44256518 | ||
Stability of the proteasome can be regulated allosterically through engagement of its proteolytic active sites. | Q46891027 | ||
Nontoxic proteasome inhibition activates a protective antioxidant defense response in endothelial cells. | Q52932265 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 25 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 13147-13159 | |
P577 | publication date | 2016-04-18 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Inhibition of Proteasome Activity Induces Formation of Alternative Proteasome Complexes | |
P478 | volume | 291 |
Q39518256 | ABA-dependent inhibition of the ubiquitin proteasome system during germination at high temperature in Arabidopsis |
Q103825994 | Conformational maps of human 20S proteasomes reveal PA28- and immuno-dependent inter-ring crosstalks |
Q92972669 | Dynamic Regulation of the 26S Proteasome: From Synthesis to Degradation |
Q93136077 | Modulation of the cell cycle regulating transcription factor E2F1 pathway by the proteasome following amino acid starvation |
Q50932512 | Multiple functions of insulin-degrading enzyme: a metabolic crosslight? |
Q56753804 | PIP30/FAM192A is a novel regulator of the nuclear proteasome activator PA28γ |
Q89598452 | Proteasome Inhibitors: Harnessing Proteostasis to Combat Disease |
Q90911106 | Proteasome activator PA200 regulates myofibroblast differentiation |
Q92923068 | Proteasomes and Several Aspects of Their Heterogeneity Relevant to Cancer |
Q92409566 | Regulation of Proteasome Activity by (Post-)transcriptional Mechanisms |
Q33720384 | The 11S Proteasomal Activator REGγ Impacts Polyglutamine-Expanded Androgen Receptor Aggregation and Motor Neuron Viability through Distinct Mechanisms |
Q95650650 | The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges |
Q88727534 | Upregulation of PSMB8 and cathepsins in the human brains of dementia with Lewy bodies |